Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of asymmetric synthesis method of escitalopram intermediate and its intermediate

A technology of escitalopram and a synthesis method, applied in the field of drug synthesis, can solve the problems of being unable to be suitable for industrialized large-scale production, low product yield, long route and the like, and achieve the effects of novel synthesis route, good product purity and high yield

Active Publication Date: 2021-06-25
HUAIYIN INSTITUTE OF TECHNOLOGY
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Non-patent literature: Curr Med Res Opin.26 (12): 2757-64; Annals of Internal Medicine.155 (11): 772-85; all introduce the synthetic technique of escitalopram intermediate, but in the prior art, according to The synthesis process of dipran intermediates often has a relatively long route and high cost, and also has the defects of low product yield and poor quality, which cannot be suitable for industrialized large-scale production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of asymmetric synthesis method of escitalopram intermediate and its intermediate
  • A kind of asymmetric synthesis method of escitalopram intermediate and its intermediate
  • A kind of asymmetric synthesis method of escitalopram intermediate and its intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Synthesis of compound (6)

[0033] Under nitrogen protection, at -30°C, add 1.0kg (5mol) of compound (7) to 5L anhydrous tetrahydrofuran into a 10L four-neck reaction flask, slowly add 2L s-BuLi (2.5M tetrahydrofuran solution), and stir for half After 1 hour, 250 g of dry ice was added, and after stirring for 1 hour, it was slowly raised to room temperature, adjusted to about pH=6.5 with 15% acetic acid, filtered, and dried to obtain 1.2 kg (4.89 mol) of compound (6), with a yield of 97.8% and a purity of 98.1%.

[0034] [M+H]+=250

[0035] Synthesis of compound (4)

[0036] At 0°C, add 1.2kg (4.89mol) of compound (6) to 6L of dichloromethane into a 10L four-neck reaction flask, slowly add 1.67kg (5mol) of triphenylphosphine chlorine complex, and monitor the reaction by TLC. The reaction was completed after 12 hours, filtered, and the filtrate was directly used for the next reaction.

[0037] Synthesis of compound (2)

[0038] Under nitrogen protection, at -20°C, 5...

Embodiment 2

[0041] Preparation of compound (1)

[0042] At -20°C, under the protection of nitrogen, add 4.4L of compound (3) (2.5M tetrahydrofuran solution) in 5L of anhydrous dichloromethane as a reaction solvent to a 20L reactor, and add the catalyst CuBr-SMe 2 21g (0.1mol) and chiral ligand T006 81g (0.1mol), after stirring for 1 hour, slowly add compound (2) 3.18kg (10.0mol) in 5L anhydrous dichloromethane solution, TLC monitors the reaction, and reacts for 12 hours After the end, it was raised to room temperature, slowly poured into 10L 5% acetic acid aqueous solution, separated, the aqueous phase was extracted twice with dichloromethane, the organic phase was combined, and the organic phase was concentrated under reduced pressure to obtain the crude product of compound (1). Recrystallized from methanol / water to obtain 3.28kg (9.59mol) of the refined product, with a molar yield of 95.9% and a purity of 99.5% by HPLC.

[0043] 1 H NMR (400MHz, DMSO-d 6 )δ7.88(s,1H),7.70–7.39(m,4H)...

Embodiment 3

[0046] According to the synthesis method of Example 1, the difference is that the reaction temperature is 20° C., the reaction solvent tetrahydrofuran is replaced by anhydrous dichloromethane, the catalyst is replaced by cuprous bromide (0.1 mol), and the chiral ligand is replaced by T005 ( 0.12mol), compound (3) (20mol) and compound (2) (20mol). Compound (1) has a molar yield of 95.1%, and a purity of 98.8% by HPLC.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an asymmetric synthesis method of an escitalopram intermediate. Firstly, the compound (2) and the compound (3) are used as starting materials, and the escitalopram is prepared through an asymmetric 1,2-addition reaction Intermediate compound (1), its reaction formula is as follows: The synthetic method route of the present invention is novel, easy and simple to operate, synthetic yield is high, product purity is good, raw material is cheap and easy to get and is suitable for the advantages such as suitability for industrialized production, simultaneously synthesized The escitalopram intermediate provides intermediate raw materials for the preparation of escitalopram.

Description

technical field [0001] The invention belongs to the technical field of medicine synthesis, and in particular relates to a synthesis method of an escitalopram intermediate and an intermediate thereof. Background technique [0002] Escitalopram (common name: Escitalopram; trade name: Cipralex), chemical name: 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroiso Benzofuran-5-carbonitrile. The molecular weight of escitalopram: 414.43; CAS registration number: 128196-01-0; the structural formula is shown in formula 1: [0003] [0004] Yidipram was developed by Lundbeek Company, and it was listed in the UK for the first time in July 2002. Escitalopram is a selective 5-hydroxytryptamine (5-HT) inhibitor, a derivative of the antidepressant citalopram (S-citalopram racemate), which acts by inhibiting the reuptake of 5-HT to enhance central nervous system serotonergic activity. Animal experiments have shown that escitalopram is a highly selective 5-HT reuptake inhibitor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C253/30C07C255/59
CPCC07B2200/07C07C253/30C07F7/1892C07C255/59
Inventor 黄燕鸽华鹏张世忠徐海清袁君许莹游庆红
Owner HUAIYIN INSTITUTE OF TECHNOLOGY